Anebulo Pharmaceuticals, Inc. (NASDAQ: ANEB) reported Q2 EPS of ($0.05), $0.08 better than the analyst estimate of ($0.13).

For earnings history and earnings-related data on Anebulo Pharmaceuticals, Inc. (ANEB) click here.